enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. IQVIA - Wikipedia

    en.wikipedia.org/wiki/IQVIA

    [28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]

  3. The Smartest Dividend Stocks to Buy With $300 Right Now - AOL

    www.aol.com/smartest-dividend-stocks-buy-300...

    Recently, the company raised its quarterly dividend by 3% to $0.70 per share, equating to an annual yield of 2.8%. ... Investors should expect at least a 10% dividend increase, according to ...

  4. IMS Health - Wikipedia

    en.wikipedia.org/wiki/IMS_Health

    IMS Health's corporate headquarters is located in Danbury, Connecticut, United States. The company's chairman and CEO is Ari Bousbib. In 1998, the parent company, Cognizant Corporation, split into two companies: IMS Health and Nielsen Media Research. After this restructuring, Cognizant Technology Solutions became a public subsidiary of IMS Health

  5. S&P 500 Dividend Aristocrats - Wikipedia

    en.wikipedia.org/wiki/S&P_500_Dividend_Aristocrats

    There are other indexes of dividend aristocrats that vary with respect to market cap and minimum duration of consecutive yearly dividend increases. Components are added when they reach the 25-year threshold and are removed when they fail to increase their dividend during a calendar year or are removed from the S&P 500.

  6. AOL latest headlines, entertainment, sports, articles for business, health and world news.

  7. Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.

  8. Ronald T. LeMay - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/ronald-t-lemay

    From January 2008 to December 2012, if you bought shares in companies when Ronald T. LeMay joined the board, and sold them when he left, you would have a -23.1 percent return on your investment, compared to a -2.8 percent return from the S&P 500.

  9. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Syngenta rejecteded another unsolicited offer from Monsanto, worth $45 billion, with management saying it undervalued the company and a merger would carry significant risks. Monsanto offered to acquire the company at a price of 449 Swiss francs per Syngenta share, with approximately 45% of the price paid in cash. [29] [30] 19 2014